AURICCHIO, ANTONIO
AURICCHIO, ANTONIO
Canakinumab in a subgroup of patients with COVID-19
2020-01-01 Ucciferri, C.; Auricchio, A.; Di Nicola, M.; Potere, N.; Abbate, A.; Cipollone, F.; Vecchiet, J.; Falasca, K.
Circulating extracellular vesicles as new inflammation marker in hiv infection
2021-01-01 Falasca, Katia; Lanuti, Paola; Ucciferri, Claudio; Pieragostino, Damiana; Cufaro, Maria Concetta; Bologna, Giuseppina; Federici, Luca; Miscia, Sebastiano; Pontolillo, Michela; Auricchio, Antonio; Del Boccio, Piero; Marchisio, Marco; Vecchiet, Jacopo
Clinical characteristics and cardiovascular implications of the dead patients for COVID-19
2021-01-01 Falasca, K.; Ucciferri, C.; Brandimarte, A.; Auricchio, A.; Pontolillo, M.; Caiazzo, L.; Vecchiet, J.
COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib
2021-01-01 Ucciferri, C.; Auricchio, A.; Marinari, S.; Vecchiet, J.; Falasca, K.
Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV
2021-01-01 Reale, M.; Ucciferri, C.; Costantini, E.; Di Nicola, M.; Porreca, A.; Di Giovanni, P.; Pontolillo, M.; Auricchio, A.; Vecchiet, J.; Falasca, K.
Efficacy of canakinumab in mild or severe COVID-19 pneumonia
2021-01-01 Falasca, Katia; DI PENTA, Myriam; Ucciferri, Claudio; Auricchio, Antonio; Di Nicola, Marta; Marchioni, Michele; Celletti, Eleonora; Sabatini, Emanuela; Cipollone, Francesco; Vecchiet, Jacopo
Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation
2022-01-01 Ucciferri, Claudio; Vecchiet, Jacopo; Auricchio, Antonio; Falasca, Katia
Parameters associated with diagnosis of COVID-19 in emergency department
2021-01-01 Ucciferri, Claudio; Caiazzo, Luca; Di Nicola, Marta; Borrelli, Paola; Pontolillo, Michela; Auricchio, Antonio; Vecchiet, Jacopo; Falasca, Katia
Pidotimod and Immunological Activation in Individuals Infected with HIV
2021-01-01 Ucciferri, Claudio; Falasca, Katia; Reale, Marcella; Tamburro, Manuela; Auricchio, Antonio; Vignale, Francesca; Vecchiet, Jacopo
Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience
2022-01-01 Ucciferri, Claudio; Auricchio, Antonio; Cutone, Carmine; Di Gasbarro, Alessandro; Vecchiet, Jacopo; Falasca, Katia
Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients
2021-01-01 Mastropasqua, L.; Toto, L.; Chiricosta, L.; Diomede, F.; Gugliandolo, A.; Silvestro, S.; Marconi, G. D.; Sinjari, B.; Vecchiet, J.; Cipollone, F.; D'Ardes, D.; Auricchio, A.; Lanzini, M.; Caputi, S.; D'Aloisio, R.; Mazzon, E.; Trubiani, O.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Canakinumab in a subgroup of patients with COVID-19 | 2020 | Ucciferri, C.; Auricchio, A.; Di Nicola, M.; Potere, N.; Abbate, A.; Cipollone, F.; Vecchiet, J.; Falasca, K. | |
| Circulating extracellular vesicles as new inflammation marker in hiv infection | 2021 | Falasca, Katia; Lanuti, Paola; Ucciferri, Claudio; Pieragostino, Damiana; Cufaro, Maria Concetta; Bologna, Giuseppina; Federici, Luca; Miscia, Sebastiano; Pontolillo, Michela; Auricchio, Antonio; Del Boccio, Piero; Marchisio, Marco; Vecchiet, Jacopo | |
| Clinical characteristics and cardiovascular implications of the dead patients for COVID-19 | 2021 | Falasca, K.; Ucciferri, C.; Brandimarte, A.; Auricchio, A.; Pontolillo, M.; Caiazzo, L.; Vecchiet, J. | |
| COVID-19 in a patient with SISTEMIC sclerosis: The role of ruxolitinib | 2021 | Ucciferri, C.; Auricchio, A.; Marinari, S.; Vecchiet, J.; Falasca, K. | |
| Effects of Probiotic Mixture Supplementation on the Immune Response to the 13-Valent Pneumococcal Conjugate Vaccine in People Living with HIV | 2021 | Reale, M.; Ucciferri, C.; Costantini, E.; Di Nicola, M.; Porreca, A.; Di Giovanni, P.; Pontolillo, M.; Auricchio, A.; Vecchiet, J.; Falasca, K. | |
| Efficacy of canakinumab in mild or severe COVID-19 pneumonia | 2021 | Falasca, Katia; DI PENTA, Myriam; Ucciferri, Claudio; Auricchio, Antonio; Di Nicola, Marta; Marchioni, Michele; Celletti, Eleonora; Sabatini, Emanuela; Cipollone, Francesco; Vecchiet, Jacopo | |
| Improving BNT162b2 mRNA Vaccine Tolerability without Efficacy Loss by Pidotimod Supplementation | 2022 | Ucciferri, Claudio; Vecchiet, Jacopo; Auricchio, Antonio; Falasca, Katia | |
| Parameters associated with diagnosis of COVID-19 in emergency department | 2021 | Ucciferri, Claudio; Caiazzo, Luca; Di Nicola, Marta; Borrelli, Paola; Pontolillo, Michela; Auricchio, Antonio; Vecchiet, Jacopo; Falasca, Katia | |
| Pidotimod and Immunological Activation in Individuals Infected with HIV | 2021 | Ucciferri, Claudio; Falasca, Katia; Reale, Marcella; Tamburro, Manuela; Auricchio, Antonio; Vignale, Francesca; Vecchiet, Jacopo | |
| Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience | 2022 | Ucciferri, Claudio; Auricchio, Antonio; Cutone, Carmine; Di Gasbarro, Alessandro; Vecchiet, Jacopo; Falasca, Katia | |
| Transcriptomic analysis revealed increased expression of genes involved in keratinization in the tears of COVID-19 patients | 2021 | Mastropasqua, L.; Toto, L.; Chiricosta, L.; Diomede, F.; Gugliandolo, A.; Silvestro, S.; Marconi, G. D.; Sinjari, B.; Vecchiet, J.; Cipollone, F.; D'Ardes, D.; Auricchio, A.; Lanzini, M.; Caputi, S.; D'Aloisio, R.; Mazzon, E.; Trubiani, O. |